‘I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety

• Main Authors: Dee Mangin, Cathy Risdon, Larkin Lamarche, Jessica Langevin, Abbas Ali, Jenna Parascandalo, Gaibrie Stephen, Johanna Trimble
• Format: Article
• Language: English
• Published: SAGE Publishing 2019-04-01
• Series: Therapeutic Advances in Drug Safety
• Online Access: https://doi.org/10.1177/2042098619838796

Background: This study explored the perspectives and experiences from patients and families around how patient/family preferences and priorities are considered in medication-related discussions and decisions within the healthcare system. Methods: We conducted a qualitative study using focus groups with residents of Southern Ontario and British Columbia ( N = 16). Three focus groups were conducted using a semi-structured focus group guide. The audiotaped focus group discussions were transcribed verbatim. A thematic analysis, using inductive coding, was completed. Results: A total of three main themes [and several sub-themes (and sub-sub-themes)] emerged from the data: patient and family expertise [ lived experience, information expert , and perceived expert roles (patient/family, healthcare provider)], perceived patient-centredness ( relationship qualities of healthcare provider and assumptions about patients ), and system ( time, coordination and communication , and culture ). Stories told by participants helped to clarify the relationships between the themes and sub-themes, leading to, what we understand as shared decision-making around medications and subsequent health outcomes. Conclusions: Our findings showed that shared decision-making resulted from both recognition and integration of the personal expertise of the patient and family in medications, and perceived patient-centredness. This is broadly consistent with the current conceptualization of evidence-based medicine. The stories told highlight the complex, dynamic, and nonlinear nature of shared decision-making for medications, and that patient priorities are not as integrated into shared decision-making about medications as we would hope. This suggests the need for developing a systematic process to elicit, record, and integrate patient preferences and priorities about medications to create space for a more patient-centred conversation.